Budesonide, fluticasone propionate, and azithromycin do not modulate the membrane vesicle release by THP-1 macrophages and respiratory pathogens during macrophage infection

Patients with more severe chronic obstructive pulmonary disease frequently experience exacerbations and it is estimated that up to 50% of these exacerbations are associated with bacterial infections. The mainstay treatment for these infection-related exacerbations constitutes the administration of g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Inflammopharmacology
Main Authors: Volgers, Charlotte, Grauls, Gert E., Hellebrand, Pauline H. M., Savelkoul, Paul H. M., Stassen, Frank R. M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5671549/
https://ncbi.nlm.nih.gov/pubmed/28528362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10787-017-0359-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados